Geode Capital Management’s Capricor Therapeutics CAPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.56M | Buy |
|
|||||
|
2025
Q1 | $8.56M | Buy |
|
|||||
|
2024
Q4 | $12.1M | Buy |
|
|||||
|
2024
Q3 | $9.71M | Sell |
|
|||||
|
2024
Q2 | $3.06M | Buy |
|
|||||
|
2024
Q1 | $2.23M | Buy |
|
|||||
|
2023
Q4 | $1.55M | Buy |
|
|||||
|
2023
Q3 | $919K | Sell |
|
|||||
|
2023
Q2 | $1.43M | Buy |
|
|||||
|
2023
Q1 | $978K | Buy |
|
|||||
|
2022
Q4 | $872K | Buy |
|
|||||
|
2022
Q3 | $1.33M | Buy |
|
|||||
|
2022
Q2 | $719K | Sell |
|
|||||
|
2022
Q1 | $760K | Buy |
|
|||||
|
2021
Q4 | $602K | Hold |
|
|||||
|
2021
Q3 | $826K | Buy |
|
|||||
|
2021
Q2 | $948K | Buy |
|
|||||
|
2021
Q1 | $802K | Buy |
|
|||||
|
2020
Q4 | $417K | Buy |
|
|||||
|
2020
Q3 | $606K | Buy |
|
|||||
|
2020
Q2 | $144K | Buy |
|
|||||
|
2020
Q1 | $15K | Hold |
|
|||||
|
2019
Q4 | $16K | Hold |
|
|||||
|
2019
Q3 | $48K | Hold |
|
|||||
|
2019
Q2 | $43K | Buy |
|
|||||
|
2019
Q1 | $55K | Hold |
|
|||||
|
2018
Q4 | $48K | Hold |
|
|||||
|
2018
Q3 | $124K | Hold |
|
|||||
|
2018
Q2 | $159K | Buy |
|
|||||
|
2018
Q1 | $104K | Hold |
|
|||||
|
2017
Q4 | $121K | Buy |
|
|||||
|
2017
Q3 | $160K | Hold |
|
|||||
|
2017
Q2 | $44K | Buy |
|
|||||
|
2017
Q1 | $154K | Buy |
|
|||||
|
2016
Q4 | $116K | Hold |
|
|||||
|
2016
Q3 | $145K | Hold |
|
|||||
|
2016
Q2 | $173K | Hold |
|
|||||
|
2016
Q1 | $111 | Hold |
|
|||||
|
2015
Q4 | $134K | Hold |
|
|||||
|
2015
Q3 | $177K | Hold |
|
|||||
|
2015
Q2 | $221K | Buy |
|